Significant Ownership of Casdin Capital, LLC
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Casdin Capital, LLC focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Eli Casdin - Eli Casdin, Managing Member
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Casdin Capital, LLC with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Casdin Capital, LLC
Significant Ownership of Casdin Capital, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| LAB | Standard BioTools Inc. | Common Stock, par value $0.001 per share | 24% | $94,784,236 | +$407,021 | 93,845,778 | +0.43% | Eli Casdin | 06 Jun 2026 |
| BLFS | BIOLIFE SOLUTIONS INC | Common Stock, par value $0.001 per share | 9.7% | $100,709,183 | 4,757,165 | 0% | Casdin Capital, LLC | 04 Jun 2026 | |
| NGNE | Neurogene Inc. | Common Stock, $0.000001 par value | 8.7% | $19,961,513 | 1,295,361 | Casdin Capital, LLC | 31 Dec 2024 | ||
| RLAY | Relay Therapeutics, Inc. | Common Stock, par value $0.001 per share | 7.5% | $110,010,236 | 13,003,574 | CASDIN CAPITAL, LLC | 31 Dec 2025 | ||
| TNYA | Tenaya Therapeutics, Inc. | Common Stock, $0.0001 par value per share | 4.3% | $3,231,826 | 6,732,971 | Casdin Capital, LLC | 04 Mar 2025 | ||
| IPSC | Century Therapeutics, Inc. | Common Stock, $0.0001 par value per share | 3.7% | $1,702,527 | 3,212,316 | Casdin Capital, LLC | 31 Mar 2025 | ||
| CDXS | Codexis, Inc. | Common Stock, par value $0.0001 per share | 0% | $0 | -$17,568,000 | 0 | -100% | CASDIN CAPITAL, LLC | 30 Sep 2025 |
Schedules 13D/G Reported by Casdin Capital, LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.